Which ETFs hold AbbVie Inc (ABBV)?
American drugmaker known for immunology medicines Skyrizi and Rinvoq, plus Botox.
39 Australian ETFs hold AbbVie Inc, a Health Care company from United States. DRUG has the biggest weighting at 6.95%. Across these funds, Australian ETF investors own about $641m of AbbVie Inc.
The ETFs with the most AbbVie Inc
All 39 ETFs that hold AbbVie Inc, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell AbbVie Inc.
Common questions
Which ETF has the most AbbVie Inc?
DRUG (Betashares Global Healthcare Currency Hedged ETF) has the highest weighting, with 6.95% of the fund in AbbVie Inc.
What is the cheapest ETF that holds AbbVie Inc?
Of the ETFs where AbbVie Inc is at least 1% of the fund, WXOZ has the lowest fee at 0.07% a year, with 1.14% in AbbVie Inc.
How much AbbVie Inc do I own with $10,000 in VGS?
About $51. VGS is the largest ETF that holds AbbVie Inc, and AbbVie Inc makes up 0.51% of it.
How many Australian ETFs hold AbbVie Inc?
39 ETFs listed on the ASX or TMX Australia hold AbbVie Inc, based on issuers' published holdings.